
Cryo-Cell International Inc.
CCEL
CCEL: Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
moreShow CCEL Financials
Recent trades of CCEL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CCEL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CCEL's company Twitter account
Number of mentions of CCEL in WallStreetBets Daily Discussion
Recent insights relating to CCEL
Recent picks made for CCEL stock on CNBC
ETFs with the largest estimated holdings in CCEL
Flights by private jets registered to CCEL